Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Cyclerion Therapeutics, Inc. (CYCN) had Stock-Based Compensation of $0.06M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.18M |
|
-- |
|
-- |
|
$3.21M |
|
$-3.21M |
|
$0.03M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.21M |
|
$-3.21M |
|
4.21M |
|
4.21M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$3.09M |
|
$0.07M |
|
$5.42M |
|
$8.51M |
|
$1.71M |
|
-- |
|
-- |
|
$1.71M |
|
$6.79M |
|
$6.79M |
|
$6.79M |
|
4.24M |
|
| Cash Flow Statement Financials | |
$-1.18M |
|
$-0.07M |
|
$0.82M |
|
$3.24M |
|
$2.82M |
|
$-0.42M |
|
|
Stock-Based Compensation |
$0.06M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.78% |
|
-46.78% |
|
-37.35% |
|
-46.78% |
|
$1.60 |
|
$-0.30 |
|
$-0.28 |
|